# 🧬 CGT 每日情报 (Daily Brief)
> **日期**: 2026-02-06 | **更新时间**: 09:20 (北京时间)
> **监控范围**: Global (In vivo/FDA) & China (NMPA/Biotech)

---

## 🌍 全球前沿 (FDA / In vivo / MNCs)
- `[13:30]` **🔥In-vivo | Invivoscribe® 推出 LeukoStrat® KMT2A + MRD 检测，以推进全球临床试验和患者管理中的高灵敏度白血病检测**
  <br><small>🇬🇧 *Invivoscribe® Launches LeukoStrat® KMT2A + MRD Assay to Advance High-Sensitivity Leukemia Testing in Clinical Trials and Patient Management Worldwide* [🔗Source](https://news.google.com/rss/articles/CBMiqgJBVV95cUxQdXc5SnJCMmlWM05GYjIzd1hCYnVXbXVqdWxpUXl2YmZ6V3h0blJJWEdaSjVzMWdQekxGTFVNeGtzLWlVaC1KN2hQUXhqc2duOGsxV25JaFFEanZFQUdmSHg3eS15TDJKS2NMSkR3c0cxZ1UxNHdKbUlONkxkNTMwRHRac00ycEhReGRYTjdZS1pDN0M0dEZlcXptaEdmVkFLS1owbEd5ZUtOREhoVnZCcVh3VTNMallKSkNBc2JDSFplMjRlcjFDQUdMQXdtZ2ppdmhQR09Ybk52UWVRWEhpSW9feDBXaFdqNVlhQkFNaXZLWjVHSmFvZ2EtRS02ODd2cUVrSllFdktDRGJvTUEyRzJST0wwU3BNX01yWnN0UXhZeVU5UVdnM2xR?oc=5)</small>

---

## 🇨🇳 中国动态 (NMPA / Domestic Players)
- `[22:36]` **CAR-T疗法新突破：BACH2蛋白如何逆转细胞耗竭，提升实体瘤治疗效果？** [🔗阅读原文](https://news.google.com/rss/articles/CBMiRkFVX3lxTFB1WHRVWDEyQjdTNEU3QWNTaVRiZ2ctbDN5VG91SjdyaGY4N3UxaWJhVFhwcXZhNkgxYWtDcDFZTXBjRXFzX1E?oc=5)
- `[22:11]` **新型CAR-T来了，癌症与自免双突破 | Science子刊封面** [🔗阅读原文](https://news.google.com/rss/articles/CBMifkFVX3lxTE5razdtdGFITHpkZUNydjdPSHU4OVh1cXozYnVsX1ZvMGdYSHRKdko0SmlNWC1tWkJWaWFnXzNiRzg3S0xKVVVjbk1PNHBrQ0ZzbzZSX2dreEZ4am5nUDVqNmdoOFdycjBqcXlydmJidE1yeUZDeFBxcGNBVjk3Zw?oc=5)
- `[17:01]` **国内首个！中源协和诱导多能干细胞（iPSC）细胞系喜获美国药监局DMF原料药备案** [🔗阅读原文](https://news.google.com/rss/articles/CBMifkFVX3lxTE9GR1RHYV9YQ0lDdDExbGhGUnZSNXJ1M0ZnV3VuZWxicUZlZGNqbHVuN1JVMERWd01fZ3BtSTNnSWNhdUFOZUEyUDYyYTIyQVRFSjBpbEZPRjJaVFpNSV9OcXlGeUM3WVlwS0VhYWZWa1oydXpWMENYbVBSUXFHZw?oc=5)
- `[11:00]` **Nature Medicine：2026年关键临床试验将塑造医学发展，细胞治疗备受关注** [🔗阅读原文](https://news.google.com/rss/articles/CBMifkFVX3lxTFB4dlJaQ19yMTJsOEVPbHhvZUh0M3JXd2tfbWVLbVlWRm9fYTRjMGt4bEJ4Q1ZXNllyV21zUEw1ZmlwUW5lUWZDc1djNXhJelhNcnhxTDYxZTBqSU5lYWdMV3MyVmdnandGdjFTaU5INy1UQ0ozUl80ZVJLd2llUQ?oc=5)
